Penington Institute is responding to the unfolding COVID-19/coronavirus outbreak by creating a series of informational resources for people who use drugs, their family and friends, and the sector.
These resources are […]
This year’s International Overdose Awareness Day was the most successful yet. Download and read the Partners’ Report to learn more about our campaign.
Frontline initiatives to prevent fatal overdose in Victoria
Deaths from unintentional overdose are growing.
These deaths are, by definition, preventable. However, there are no silver bullets – sophisticated and evidence-based responses are […]
Penington Institute, the not-for-profit convenor of International Overdose Awareness Day, is today launching the website, Life Savers,1 a brief guide to treatment for people concerned about […]
The toll of unintentional overdose deaths in Australia: Penington Institute
Australia’s Annual Overdose Report 2019 reveals that unintentional overdose continues to be a significant cause of death in Australia.
The continued growth in unintentional […]
Lyrica®: Filling a pain fap or emerging threat? Penington institute recently hosted a public information forum with experts speakers discussing pregabalin (sold as Lyrica®). Subsidised as an antiepileptic […]
One of the most urgent public health issues facing the new government will be Australia’s dependence on prescription opioids, independent drug research, policy and education organisation Melbourne-based Penington Institute, said […]
Use of pregabalin (sold as Lyrica®) has skyrocketed in recent years. Anecdotal reports indicate problematic use is becoming more common including amongst people who inject drugs.
In Australia, pregabalin is a […]
Leading independent drug research, policy and education organisation, Penington Institute, has today celebrated the public health achievements of Australia’s 23rd Prime Minister the Hon RJL Hawke AC GCL on the […]
Penington Institute urges Canberra to show ‘courage, imagination and boldness’ in tackling Australia’s opioid death rate
Leading independent drug research, policy and education organisation, Penington Institute, has welcomed today’s (27 February) announcement by the Commonwealth Government that it will fund a $7.2 million trial of naloxone […]